Related Experiment Video
Updated: Jul 19, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Hemicrania Continua: An Update
Haidar M Al-Khazali1,2,3,4, Rune Häckert Christensen1,2,3, Giorgio Lambru5,6
1Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Insights
Hemicrania Continua (HC) is a rare headache disorder. Diagnosis requires a complete response to indomethacin, but more research is needed for better understanding and management of this condition.
Area of Science:
- Neurology
- Headache Medicine
Background:
- Hemicrania Continua (HC) is a rare, disabling primary headache disorder.
- Characterized by persistent unilateral headache with autonomic symptoms and agitation.
- Diagnosis relies on an absolute response to indomethacin.
Purpose of the Study:
- To provide a comprehensive overview of Hemicrania Continua.
- To cover epidemiology, clinical presentation, diagnosis, and management.
- To highlight areas needing further research.
Main Methods:
- Literature review of Hemicrania Continua.
- Analysis of diagnostic criteria and treatment response.
- Synthesis of current knowledge on HC.
Main Results:
- HC diagnosed in approximately 1.8% of adult headache patients in tertiary care.
- Common symptoms include lacrimation, conjunctival injection, and agitation.
- Existing literature is limited by methodological issues and unclear diagnostic criteria.
Conclusions:
- More rigorous studies are essential for a better understanding of HC.
- Improved understanding will facilitate better disease management.
- Current diagnostic clarity regarding indomethacin response needs enhancement.
Purpose Of Review:
Hemicrania Continua (HC) is a rare and disabling primary headache disorder that is characterized by persistent, unilateral headache with ipsilateral, cranial autonomic symptoms and restlessness or agitation. The diagnosis requires patients to experience an absolute response to therapeutic doses of indomethacin.
Recent Findings:
HC is diagnosed in in about 1.8% of adult patients who were evaluated for headache in tertiary care services, albeit this estimate should be interpreted with caution. The most prevalent accompanying symptoms appear to be lacrimation, conjunctival injection and restlessness or agitation. However, the available literature is limited by methodologic issues, and the current diagnostic criteria lack clarity on what defines absolute response to indomethacin. More rigorous studies are thus needed to improve our understanding of HC which, in turn, will facilitate better disease management in clinical practice. Here, we provide a comprehensive overview of HC, including its epidemiology, clinical presentation, diagnostic evaluation, and management.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Glaucoma: Overview
Mania and Antimanic Drugs: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Vascular Spasm

